| A2AR | Adenosine A2A receptor |
| ADHD | Attention deficit hyperactivity disorder |
| AlphaScreen | Amplified luminescent proximity homogeneous assay screen (based on luminescent oxygen channeling immunoassay) |
| BBB | Blood–brain barrier |
| BHT-920 | 5,6,7,8-Tetrahydro-6-(2-propen-1-yl)-4H-thiazolo[4,5-d]azepin-2-amine dihydrochloride |
| BiFC | Bimolecular fluorescence complementation |
| BRET | Bioluminescence resonance energy transfer |
| CGS21680 | 2-[p-(2-carboxyethyl)phenethylamino]-5’- N-ethylcarboxamido-adenosine |
| CNS | Central nervous system |
| CSC | 8-(3-Chlorostyryl)caffeine |
| D2R | Dopamine D2 receptor |
| DMFP | Desmethoxyfallypride |
| DMPX | 3,7-Dimethyl-1-propargylxanthine |
| FCP | Fluoroclebopride |
| FEBF | Fluorethyl-2,3-dihydrobenzofuran |
| FESP | Fluoroethyl-spiperone |
| FPE | Fluoropropyl-epidepride |
| FPSP | Fluoropropyl-spiperone |
| FRET | Fluorescence resonance energy transfer |
| MABN | 2,3-dimethoxy-N-[9-(4-fluorobenzyl)-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide |
| MBP | 2,3-dimethoxy-N-[1-(4-fluorobenzyl)piperidin4yl]benzamide |
| MNPA | Methoxy-N-n-propylnorapomorphine |
| MSN | Medium spiny neuron |
| MECA | 5′-(N-methyl)carboxamido-adenosine |
| NECA | 5’-(N-ethyl)carboxamido-adenosine |
| NMSP | N-methyl-spiperone |
| NPA | N-n-propylnorapomorphine |
| PANNS | Positive and Negative Syndrome Scale |
| PIA | N6-R-phenylisopropyladenosine |
| PPHT | (+/-)-2-(N-phenethyl-N-propyl)amino-5-hydroxytetralin |
| TMSX | [7-methyl-11C]-(E)-8-(3,4,5-trimethoxystyryl)-1,3,7-trimethylxanthine |
| XCC | 8-(p-carboxymethyloxy)phenyl-1,3 dipropylxanthine |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.